Pseudotumor cerebri historical perspective

Jump to navigation Jump to search

Pseudotumor cerebri Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating pseudotumor cerebri from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pseudotumor cerebri historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pseudotumor cerebri historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pseudotumor cerebri historical perspective

CDC on Pseudotumor cerebri historical perspective

Pseudotumor cerebri historical perspective in the news

Blogs on Pseudotumor cerebri historical perspective

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Pseudotumor cerebri historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Historical Perspective

Discovery

  • Nonne in 1904 named this disease “pseudotumor cerebri”[1] and Foley named it “benign intracranial hypertension” in 1955.[2]
  • They both described it as increased intracranial pressure with no brain tumor. Buchheit et al  suggested that the terms “benign” and “pseudtumor” are not appropriate and introduced the name “Idiopathic intracranial hypertesion”.[3]
  • For the first time, Walter Dandy described diagnostic criteria for idiopathic intracranial hypertension in 1937 and then modified by in 1985 and Friedman and Jacobson i 2002.[4][5][6]

Landmark Events in the Development of Treatment Strategies

In [year], [diagnostic test/therapy] was developed by [scientist] to treat/diagnose [disease name].

Famous Cases

  • The first patient with idiopathic intracranial hypertension was introduced by Quincke in 1893. He described 10 cases with headache, papilledema and increased CSF pressure with normal cell count, glucose and protein.[1]

References

  1. 1.0 1.1 Pearce JM (December 2009). "From pseudotumour cerebri to idiopathic intracranial hypertension". Pract Neurol. 9 (6): 353–6. doi:10.1136/jnnp.2009.194837. PMID 19923117.
  2. FOLEY J (1955). "Benign forms of intracranial hypertension; toxic and otitic hydrocephalus". Brain. 78 (1): 1–41. PMID 14378448.
  3. Corbett JJ, Thompson HS (October 1989). "The rational management of idiopathic intracranial hypertension". Arch. Neurol. 46 (10): 1049–51. PMID 2679506.
  4. Dandy WE (October 1937). "INTRACRANIAL PRESSURE WITHOUT BRAIN TUMOR: DIAGNOSIS AND TREATMENT". Ann. Surg. 106 (4): 492–513. PMC 1390605. PMID 17857053.
  5. Smith JL (March 1985). "Whence pseudotumor cerebri?". J Clin Neuroophthalmol. 5 (1): 55–6. PMID 3156890.
  6. Friedman DI, Jacobson DM (November 2002). "Diagnostic criteria for idiopathic intracranial hypertension". Neurology. 59 (10): 1492–5. PMID 12455560.

Template:WH Template:WS